Sotera Health Company Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	51.38	-233.57	116.88	-38.62	-20.85	-5.87
Depreciation & Amortization	157.93	145.55	150.9	143.56	146.72	146.82
Share-Based Compensation	32.24	21.21	13.87	10.99	6.88	6.94
Other Operating Activities	-389.27	344.77	-0.11	4.65	16.29	-28.33
Operating Cash Flow	-147.73	277.96	281.55	120.59	149.04	119.56
Operating Cash Flow Growth	-	-1.27%	133.48%	-19.09%	24.65%	-
Capital Expenditures	-214.98	-182.38	-102.16	-53.51	-57.26	-72.61
Acquisitions	0	0.45	-56.97	-105.19	0	162.82
Other Investing Activities	0.07	0.03	-0.7	-	-	6.43
Investing Cash Flow	-214.91	-181.9	-159.83	-158.69	-57.26	96.64
Dividends Paid	0	0	0	0	-691.17	-175.85
Share Issuance / Repurchase	0	0	0	1,122	0	0
Debt Issued / Paid	271.86	199.97	-106.79	-1,047.07	566.48	-14.63
Other Financing Activities	-5.9	-2.21	-10.49	-1.46	-1.34	-1.38
Financing Cash Flow	265.96	197.76	-117.29	73.43	-126.03	-191.86
Exchange Rate Effect	2.04	-4.46	0.04	4.11	0.49	-3.68
Net Cash Flow	-94.64	289.37	4.47	39.43	-33.76	20.67
Free Cash Flow	-362.71	95.58	179.38	67.08	91.78	46.95
Free Cash Flow Growth	-	-46.72%	167.42%	-26.92%	95.49%	-
Free Cash Flow Margin	-34.57%	9.52%	19.26%	8.20%	11.79%	6.29%
Free Cash Flow Per Share	-1.29	0.34	0.64	0.28	0.40	0.20

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).